Instant NanoBiosensors, based in the Nangang National Biotechnology Research Park, is a leader in precision medical diagnostics. Our team’s diverse expertise in research, technology development, product design, and business strategy enable our company to lead in innovation, technological advancement, and market validation. This cohesive team drives our success in the competitive biotech industry. With subsidiaries in the United States and the Netherlands, our global impact spans two key business segments.

In the genetic testing domain, we are driving the “Next-Generation Genetic Testing Revolution” through our proprietary equipment and reagents. Our solutions streamline clinical genomics by automating every step, from sample preparation to sequencing, data analysis, and report generation. This allows hospitals to perform precise, in-house diagnostics, delivering fast and accurate reports tailored to individual patient care and treatment.

Our protein testing division focuses on advanced blood biomarker detection for Alzheimer’s disease, where we have made significant international progress. Collaborating with leading biotech firms, we are jointly developing groundbreaking diagnostic tools for Alzheimer’s. Supported by the European Union and the Alzheimer’s Drug Discovery Foundation, with backing from Bill Gates, we are pioneering the $15 billion global Alzheimer’s detection market, driving innovation and expanding healthcare possibilities.

• Light Sensing Biomarker Analyzer, leveraging patented FOPPR (Fiber Optic Particle Plasmon Resonance) and IN-Chip (auto-flowing microfluidic chip) technologies, holds over 35 global patents in the life sciences research and in vitro diagnostics markets. It enables customers to reliably detect protein biomarkers at extremely low concentrations (across 5 orders of magnitude) in blood, serum, and other fluids—concentrations that are often undetectable using conventional analog immunoassay technologies. Additionally, it empowers researchers to identify and validate novel protein biomarkers present at very low levels, which have been discovered using advanced technologies like mass spectrometry.
• INVISION Embedded Precision Medicine Solution revolutionizes clinical genomics by automating and streamlining processes from sample preparation to sequencing, data analysis, and report interpretation.
  Use of Technologies:
  • Automated Clinical Sample Processing (Hardware System) 
Our solution incorporates advanced automated instruments for nucleic acid extraction and sequencing library preparation, significantly reducing the risk of human error and contamination. These innovations ensure higher accuracy and efficiency in clinical sample processing.
  • iNA DimerOFF Multiplex NGS AML/CML Monitoring Kits (Reagent) 
This proprietary technology reduces sequencing library preparation time from 20 hours to just 6 hours. It enhances sequencing quality and efficiency, minimizes costs and resource usage, optimizes sample utilization, and ensures superior data interpretation, providing quicker results for clinicians.
  • One-Click Data Analysis and Interpreted Clinical Reports (Analysis and Report)
 Our One-Click Data Analysis Pipeline allows hospitals and clinics to efficiently analyze genetic data without requiring bioinformatics expertise. The system automates sequencing data processing, identifies key genetic mutations, and delivers clear, actionable insights. Customizable templates and automatic interpretation capabilities accelerate report generation, simplifying the workflow for medical staff and enabling faster, more accurate treatment decisions.
  • IT Architecture: Data Integration, Security, and Scalability (IT and Security)
 The system ensures secure transmission and storage of patient genetic data, complying with international data protection regulations. It integrates seamlessly with hospital information systems (HIS), enabling smooth data transfer and incorporation into clinical workflows. The scalable IT architecture is designed to accommodate various sample volumes and support healthcare facilities of all sizes, from small clinics to large hospitals.

• Light Sensing Biomarker Analyzer: Priced at a quarter of existing products, it makes advanced diagnostics accessible, especially for underserved populations. Its user-friendly design allows community healthcare providers to perform tests efficiently without specialized training. The high sensitivity of our product enables early and accurate detection of biomarkers at very low concentrations. This early detection facilitates timely intervention, which can prevent or delay the progression of neurodegenerative diseases like Alzheimer’s. By improving early diagnosis and treatment, our solution enhances healthcare access and helps reduce long-term costs, alleviating the economic burden on healthcare systems.
• INVISION Embedded Precision Medicine Solution: A proprietary end-to-end solution from sample preparation to sequencing, data analysis and interpreted report designed to provide accurate, rapid, and cost-effective genetic testing.